Explore the forefront of interventional cardiology innovation with the Jon DeHaan Foundation Award competition, featuring pioneering solutions for valvular heart disease and mechanical support. This session highlights novel devices such as TriFlo for tricuspid regurgitation, the extravascular ventricular assist device (eVAD System), and the first-in-human experience...

Watch this EuroPCR 2026 session to better understand how lesion preparation strategies can be optimised in complex PCI using directional scoring balloon technology with DK Score Pro.

Clinical evidence is reviewed, including insights from the SCORE CHINA registry, alongside practical considerations for integrating this approach into routine...

Innovations in heart failure care are transforming patient management, from real-time, non-invasive congestion monitoring to advanced mechanical support systems. This session presents the Anusar congestion assessment tool, early clinical data on the NuPulse intravascular ventricular assist system for ambulatory support, and explores AI-driven voice biomarker technology...

Management of pulmonary embolism is increasingly shifting toward interventional strategies, where timing, patient selection and procedural expertise play a central role in improving outcomes.

Large-bore thrombectomy is examined as a key option within contemporary PE treatment, focusing on when intervention is most appropriate and how to optimise...

Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is an individual participant data meta-analysis of 4 randomised controlled trials...

In this review, Henryk Dreger explores the complex interplay between aortic stenosis and coronary artery disease, highlighting the latest evidence on PCI timing and its implications for clinical decision-making.

Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.